Investigation of Mangiferin, as a Promising Natural Polyphenol Xanthone on Multiple Targets of Alzheimer's Disease

Journal of Biologically Active Products from Nature

Volumn 4, Issue 2, 2014, Pages 111-119

  Sethiya, Neeraj K ^a   Mishra, S H ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Amnesia; Inhibition; Lipoxygenase; Neuroprotection

Indexed keywords

EID: 84929322010     PISSN: 22311866     EISSN: 22311874     Source Type: Journal    
DOI: 10.1080/22311866.2014.921121     Document Type: Article

References (37)

1. Zhang, H.Y., (2005). One compound multiple targets strategy to combat Alzheimers disease. FEBS. Letters. 579: 5260–5264. doi: 10.1016/j.febslet.2005.09.006
2. Limpeanchob. N., Jaipan, S., Rattanakaruna, S., Phrompittayarat, W., Ingkaninan, K., (2008). Neuroprotective effect of Bacopa monnieri on β-amyloid-induced cell death in primary cortical culture. J. Ethnopharmacol. 120: 112–117. doi: 10.1016/j.jep.2008.07.039
3. Mora, F., Segovia, G., del-Arco, A., (2007). Aging, plasticity and environmental enrichment: structural changes and neurotransmitter dynamics in several areas of the brain. Brain. Res. Rev. 55: 78–88. doi: 10.1016/j.brainresrev.2007.03.011
4. Hostettmann, K., Wagner, H., (1977). Xanthone glycosides. Phytochemistry. 16: 821–829. doi: 10.1016/S0031-9422(00)86673-X
5. Sethiya, N.K., Patel, M.B., Mishra, S.H., (2010). Phyto-pharmacological Aspects of Canscora decussata Roem & Schult. Phcog. Rev. 4: 49–57.
6. Kokotkiewicz, A., Wnuk, M., Bucinski, A., Luczkiewicz, M., (2009). In vitro cultures of Cyclo- pia plants (honeybush) as a source of bioactive xanthones and flavanones. Z. Naturforsch. C. 64: 533–540.
7. Kitanova, G.M., Nedialkova, P.T., (1998). Mangiferin and isomangiferin in some Hypericum species. Biochem. Sys. Ecol. 26: 647–653.
8. Rahman, A.U., Sumaira, H., Muhammad, I.C., Bilge, S., Ahmed, A., Hina, S., Shazia, A., Ilkay, O., Gurbuz, I., Ayanoglu, F., (2010). New and Known Constituents from Iris unguicularis and Their Antioxidant Activity. Heterocycles. 82: 813–824. doi: 10.3987/COM-10-S(E)6
9. Smith, D.M., Harborne, J.B., (1971). Xanthones in the Appalachian Asplenium complex. Phyto- chemistry. 10: 2117–2119.
10. Miura, T., Ichiki, H., Iwamoto, N., Kato, M., Kubo, M., Sasaki, H., Okada, M., Ishida, T., Seino, Y., Tanigawa, K., (2001). Antidiabetic activity of the rhizome of Anemarrhena asphode- loides and active components, mangiferin and its glucoside. Biol. Pharm. Bull. 24: 1009–1011.
11. Shah, K.A., Patel, M.B., Patel, R.J., Parmar, P.K., (2010). Mangifera indica (mango). Phcog. Rev. 4: 42–48. doi: 10.4103/0973-7847.65325
12. Matkowski, A., Kuss, P., Goralska, E., Wozniak, D., (2013). Mangiferin - a bioactive xanthonoid, not only from mango and not just antioxidant. Mini. Rev. Med. Chem. 13: 439–455.
13. Jung, K., Lee, B., Han, S.J., Ryu, J.H., Kim, D.H., (2009). Mangiferin ameliorates scopolamine- induced learning deficits in mice. Biol. Pharm. Bull. 32: 242–246.
14. Vyas, A., Syeda, K., Ahmad, A., Padhye, S., Sarkar, F.H., (2012). Perspectives on medicinal properties of mangiferin. Mini. Rev. Med. Chem. 12: 412–425.
15. Prabhu, S., Narayan, S., Devi, C.S., (2009). Mechanism of protective action of mangiferin on suppression of inflammatory response and lysosomal instability in rat model of myocardial infarction. Phytother. Res. 23: 756–760. doi: 10.1002/ptr.2549
16. LePage, K.T, Dickey, R.W., Gerwick, W.H., Jester, E.L., Murray, T.F., (2005). On the use of neuro-2a neuroblastoma cells versus intact neurons in primary culture for neurotoxicity studies. Crit. Rev. Neurobiol. 17: 27–50.
17. Tada, H., Shiho, O., Kuroshima, K., Koyama, M., Tsukamoto, K., (1986). An improved colori- metric assay for interleukin. J. Immunol. Methods. 93: 157–165.
18. Sethiya, N.K., Nahata, A., Dixit, V.K., Mishra, S.H., (2012). Cognition boosting effect of Canscora decussata (a South Indian Shankhpushpi). Eur. J. Integr. Med. 4: 113–121.
19. Kuaraswamy, M.V., Satish, S., (2008). Free radical scavenging activity and lipoxygenase inhi- bition of Woodfordia fructicosa Kurz and Betula utilis Wall. Afr. J. Biotechnol. 7: 2013–2016.
20. Bortolomeazzi, R., Sebastianutto, N., Toniolo, R., Pizzariello, A., (2007). Comparative evalua- tion of the antioxidant capacity of smoke ûavouring phenols by crocin bleaching inhibition, DPPH radical scavenging and oxidation potential. Food. Chem. 100: 1481–1489. doi: 10.1016/j.foodchem.2005.11.039
21. Benzie, I.F.F., Strain, J.J., (1996). The ferric reducing ability of plasma as a measure of ‘‘antioxidant power’’ the FRAP assay. Anal. Biochem. 239: 70–76. doi: 10.1006/abio.1996.0292
22. Prieto, P., Pineda, M., Aguilar, M., (1999). Spectrophotometric quantitation of antioxidant capacity through the formation of phosphomolybdenum complex: speciûc application to deter- mination of vitamin E. Anal. Biochem. 269: 337–341. doi: 10.1006/abio.1999.4019
23. Cook, L., Weidley, E., (1957). Behavioural effect of some psychopharmacological agents. Ann. N. Y. Acad. Sci. 66: 740–752. doi: 10.1111/j.1749-6632.1957.tb40763.x
24. Ali, E.H.A., Arafa, N.M.S., (2011). Comparative protective action of curcumin, memantine and diclofenac against scopolamine-induced memory dysfunction. Fitoterapia. 82: 601–608. doi: 10.1016/j.fitote.2011.01.016
25. Csermely, P., Agoston, V., Pongor, S., (2005). The efficiency of multi-target drugs: the network approach might help drug design. Trends. Pharmacol. Sci. 26: 178–182.
26. Ji, H.F., Zhang, H.Y., (2005). A new strategy to combat Alzheimer's disease. Combining radical scavenging potential with metal protein attenuating ability in one molecule. Bioorg. Med. Chem. Lett. 15: 21–24. doi: 10.1016/j.bmcl.2004.10.047
27. Bolognesi, M.L., Rosini, M., Andrisano, V., Bartolini, M., Minarini, A., Tumiatti, V., Melchiorre, C., (2009). MTDL design strategy in the context of Alzheimer 's disease: from lipocrine to memoquin and beyond. Curr. Pharm. Des. 15: 601–613. doi: 10.2174/138161209787315585
28. Biradar, S.M., Joshi, H., Chheda, T.K., (2012). Neuropharmacological effect of mangiferin on brain cholinesterase and brain biogenic amines in the management of Alzheimer's disease. Eur. J. Pharmacol. 683: 140–147. doi: 10.1016/j.ejphar.2012.02.042
29. Puttfarcken, P.S., Manelli, A.M., Neilly, J., Frail, D.E., (1996). Inhibition of age-induced beta- amyloid neurotoxicity in rat hippocampal cells. Exp. Neurol. 138: 73–81. doi: 10.1006/exnr.1996.0048
30. Bruce, A.J., Malfroy, B., Baudry, M., (1996). Beta-amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc. Natl. Acad. Sci. U.S.A. 93: 2312–2316.
31. Vinutha, B., Prashanth, D., Salma, K., Sreeja, S.L., Pratiti, D., Padmaja, R., Radhika, S., Amit, A., Venkateshwarlu, K., Deepak, M., (2007). Screening of selected Indian medicinal plants for acetylcholinesterase inhibitory activity. J. Ethnopharmacol. 109: 359–363. doi: 10.1016/j.jep.2006.06.014
32. Bhattacharjee, S., (2007). Reactive oxygen species and oxidative burst: roles in stress, senescence and signal transduction in plants. Curr. Sci. 89: 1113–1121.
33. Garrido, G., Gonzalez, D., Lemus, Y., Garcia, D., Lodeiro, L., Quintero, G., Delporte, C., Nunez-Selles, A.J., Delgado, R., (2004). In vivo and in vitro anti-inflammatory activity of Mangifera indica L. extracts (VIMANG®). Pharmacol. Res. 50: 143–149. doi: 10.1016/j.phrs.2003.12.003
34. Mirza, R.H., Chi, N., Chi, Y., (2013). Therapeutic Potential of the Natural Product Mangiferin in Metabolic Syndrome. J. Nutr. Ther. 2: 74–79.
35. Sethiya, N.K., Raja, M.K.M.M., Mishra, S.H., (2013). Antioxidant markers based thin layer chromotography-2-diphenyl-1-picrylhydrazyl differentiation on four commercialized botanical sources of Shankhpushpi (Medhya Rasayana): A preliminary assessment. J. Adv. Pharm. Tech. Res. 4 (1): 25–30.
36. Sethiya, N.K., Nahata, A., Dixit, V.K., Mishra, S.H., (2009). Shankhpushpi: Cognition boosting ayurvedic medicine- An update. Zhong. Xi. Yi. Jie. He. Xue. Bao. 7 (11): 1001–1022.
37. st edition, pp 1-95. (ISBN No. 978-3-659-26050-6)